3bar,

your suggestion to use OSK.to as a valuation model comparison for TCM really makes sense.

After going through OSK's Q2 report , TCM's @ $10 is a good start..........IMO

http://www.osisko.com/documents/files/OSK_May_11_2012_Results_Call_v2.pdf